Rhumbline Advisers Nevro Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Nevro Corp stock. As of the latest transaction made, Rhumbline Advisers holds 63,688 shares of NVRO stock, worth $287,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,688
Previous 58,995 7.95%
Holding current value
$287,869
Previous $496,000 28.43%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$4.71 - $10.1 $22,104 - $47,399
4,693 Added 7.95%
63,688 $355,000
Q2 2024

Aug 01, 2024
BUY
$7.96 - $13.59 $22,574 - $38,541
2,836 Added 5.05%
58,995 $496,000
Q1 2024

May 09, 2024
BUY
$13.56 - $20.78 $16,665 - $25,538
1,229 Added 2.24%
56,159 $810,000
Q4 2023

Feb 08, 2024
SELL
$14.18 - $22.31 $2,070 - $3,257
-146 Reduced 0.27%
54,930 $1.18 Million
Q3 2023

Nov 09, 2023
BUY
$18.22 - $25.85 $4,318 - $6,126
237 Added 0.43%
55,076 $1.06 Million
Q2 2023

Aug 08, 2023
BUY
$22.62 - $39.32 $175,508 - $305,083
7,759 Added 16.48%
54,839 $1.39 Million
Q1 2023

May 11, 2023
BUY
$30.17 - $41.11 $22,446 - $30,585
744 Added 1.61%
47,080 $1.7 Million
Q4 2022

Feb 14, 2023
BUY
$36.43 - $49.4 $56,757 - $76,965
1,558 Added 3.48%
46,336 $1.84 Million
Q3 2022

Nov 10, 2022
BUY
$40.66 - $53.03 $135,601 - $176,855
3,335 Added 8.05%
44,778 $2.09 Million
Q2 2022

Aug 11, 2022
BUY
$40.85 - $77.67 $216,790 - $412,194
5,307 Added 14.69%
41,443 $1.82 Million
Q1 2022

May 12, 2022
BUY
$59.95 - $92.06 $12,589 - $19,332
210 Added 0.58%
36,136 $2.61 Million
Q4 2021

Feb 10, 2022
SELL
$81.07 - $121.29 $54,803 - $81,992
-676 Reduced 1.85%
35,926 $2.91 Million
Q3 2021

Nov 12, 2021
BUY
$101.99 - $166.36 $62,825 - $102,477
616 Added 1.71%
36,602 $4.26 Million
Q2 2021

Aug 05, 2021
SELL
$141.6 - $179.06 $221,887 - $280,587
-1,567 Reduced 4.17%
35,986 $5.97 Million
Q1 2021

May 06, 2021
SELL
$132.81 - $182.18 $649,573 - $891,042
-4,891 Reduced 11.52%
37,553 $5.24 Million
Q4 2020

Feb 10, 2021
BUY
$138.17 - $184.34 $194,819 - $259,919
1,410 Added 3.44%
42,444 $7.35 Million
Q3 2020

Nov 12, 2020
SELL
$114.09 - $145.51 $1.28 Million - $1.64 Million
-11,242 Reduced 21.51%
41,034 $5.72 Million
Q2 2020

Aug 13, 2020
BUY
$89.45 - $129.85 $788,859 - $1.15 Million
8,819 Added 20.29%
52,276 $6.25 Million
Q1 2020

May 06, 2020
BUY
$70.23 - $144.31 $40,031 - $82,256
570 Added 1.33%
43,457 $4.35 Million
Q4 2019

Feb 05, 2020
BUY
$76.41 - $117.54 $169,248 - $260,351
2,215 Added 5.45%
42,887 $5.04 Million
Q3 2019

Oct 23, 2019
SELL
$61.52 - $91.1 $21,285 - $31,520
-346 Reduced 0.84%
40,672 $3.5 Million
Q2 2019

Aug 14, 2019
BUY
$58.04 - $66.99 $167,967 - $193,869
2,894 Added 7.59%
41,018 $2.66 Million
Q1 2019

May 01, 2019
SELL
$35.52 - $62.62 $33,175 - $58,487
-934 Reduced 2.39%
38,124 $2.38 Million
Q4 2018

Jan 31, 2019
BUY
$35.43 - $56.29 $435,824 - $692,423
12,301 Added 45.97%
39,058 $1.52 Million
Q3 2018

Nov 07, 2018
SELL
$44.22 - $75.47 $78,180 - $133,430
-1,768 Reduced 6.2%
26,757 $1.53 Million
Q2 2018

Aug 06, 2018
BUY
$72.38 - $92.5 $61,957 - $79,180
856 Added 3.09%
28,525 $2.28 Million
Q1 2018

May 02, 2018
SELL
$69.46 - $88.57 $28,825 - $36,756
-415 Reduced 1.48%
27,669 $2.4 Million
Q4 2017

Feb 09, 2018
SELL
$65.94 - $93.31 $339,656 - $480,639
-5,151 Reduced 15.5%
28,084 $1.94 Million
Q3 2017

Nov 06, 2017
BUY
$80.87 - $91.08 $2.69 Million - $3.03 Million
33,235
33,235 $3.02 Million

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email